The global dPCR market is expected to grow at a CAGR of around 8.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for rapid and accurate diagnostic tests, growing number of research laboratories and academic institutes, and rising prevalence of infectious diseases.
The global dPCR market is segmented on the basis of type into consumables and instruments; on the basis of application into research laboratories and academic institutes, pharma and biotech companies, hospitals and diagnostic centers, clinical research organizations (CROs), forensic laboratories; on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) & Middle East & Africa (MEA).
- The dPCR market is expected to grow due to the increasing demand for rapid and accurate detection of pathogens in food, water, and other biological samples.
- The dPCR market is also expected to grow due to the increasing need for rapid and accurate detection of pathogens in food, water, and other biological samples as well as the growing number of emerging infectious diseases such as Zika virus infection which has led to an increased demand for rapid diagnostic tests that can be used in resource-limited settings with limited access to laboratory facilities or trained personnel.
- Increasing prevalence rates of infectious diseases such as HIV/AIDS are also driving growth in the dPCR market because these infections require early diagnosis which can be achieved through PCR testing methods such as dPCRs that are able detect low levels of DNA sequences from pathogens present in blood or tissue samples within hours or days after infection occurs.
Industry Growth Insights published a new data on “dPCR Market”. The research report is titled “dPCR Market research by Types (Consumables, Instruments), By Applications (Research Laboratories and Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations, Forensic Laboratories), By Players/Companies Bio-Rad Laboratories, Fluidigm, RainDance Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company, Exiqon, Formulatrix, Promega Corporation, Sigma-Aldrich, Stilla Technologies”.
Scope Of The Report
Report Attributes
Report Details
Report Title
dPCR Market Research Report
By Type
Consumables, Instruments
By Application
Research Laboratories and Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations, Forensic Laboratories
By Companies
Bio-Rad Laboratories, Fluidigm, RainDance Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company, Exiqon, Formulatrix, Promega Corporation, Sigma-Aldrich, Stilla Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global dPCR Market Report Segments:
The global dPCR market is segmented on the basis of:
Types
Consumables, Instruments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Laboratories and Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations, Forensic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- Fluidigm
- RainDance Technologies
- Thermo Fisher Scientific
- Becton
- Dickinson and Company
- Exiqon
- Formulatrix
- Promega Corporation
- Sigma-Aldrich
- Stilla Technologies
Highlights of The dPCR Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Consumables
- Instruments
- By Application:
- Research Laboratories and Academic Institutes
- Pharma and Biotech Companies
- Hospitals and Diagnostic Centers
- Clinical Research Organizations
- Forensic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the dPCR Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DPCR is a molecular biology technique that uses DNA sequencing to identify specific genes or regions of the genome.
Some of the major players in the dpcr market are Bio-Rad Laboratories, Fluidigm, RainDance Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company, Exiqon, Formulatrix, Promega Corporation, Sigma-Aldrich, Stilla Technologies.
The dpcr market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. dPCR Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. dPCR Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. dPCR Market - Supply Chain
4.5. Global dPCR Market Forecast
4.5.1. dPCR Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. dPCR Market Size (000 Units) and Y-o-Y Growth
4.5.3. dPCR Market Absolute $ Opportunity
5. Global dPCR Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. dPCR Market Size and Volume Forecast by Type
5.3.1. Consumables
5.3.2. Instruments
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global dPCR Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. dPCR Market Size and Volume Forecast by Application
6.3.1. Research Laboratories and Academic Institutes
6.3.2. Pharma and Biotech Companies
6.3.3. Hospitals and Diagnostic Centers
6.3.4. Clinical Research Organizations
6.3.5. Forensic Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global dPCR Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. dPCR Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global dPCR Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. dPCR Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global dPCR Demand Share Forecast, 2019-2026
9. North America dPCR Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America dPCR Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America dPCR Market Size and Volume Forecast by Application
9.4.1. Research Laboratories and Academic Institutes
9.4.2. Pharma and Biotech Companies
9.4.3. Hospitals and Diagnostic Centers
9.4.4. Clinical Research Organizations
9.4.5. Forensic Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America dPCR Market Size and Volume Forecast by Type
9.7.1. Consumables
9.7.2. Instruments
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America dPCR Demand Share Forecast, 2019-2026
10. Latin America dPCR Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America dPCR Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America dPCR Market Size and Volume Forecast by Application
10.4.1. Research Laboratories and Academic Institutes
10.4.2. Pharma and Biotech Companies
10.4.3. Hospitals and Diagnostic Centers
10.4.4. Clinical Research Organizations
10.4.5. Forensic Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America dPCR Market Size and Volume Forecast by Type
10.7.1. Consumables
10.7.2. Instruments
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America dPCR Demand Share Forecast, 2019-2026
11. Europe dPCR Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe dPCR Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe dPCR Market Size and Volume Forecast by Application
11.4.1. Research Laboratories and Academic Institutes
11.4.2. Pharma and Biotech Companies
11.4.3. Hospitals and Diagnostic Centers
11.4.4. Clinical Research Organizations
11.4.5. Forensic Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe dPCR Market Size and Volume Forecast by Type
11.7.1. Consumables
11.7.2. Instruments
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Markt Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe dPCR Demand Share, 2019-2026
12. Asia Pacific dPCR Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific dPCR Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific dPCR Market Size and Volume Forecast by Application
12.4.1. Research Laboratories and Academic Institutes
12.4.2. Pharma and Biotech Companies
12.4.3. Hospitals and Diagnostic Centers
12.4.4. Clinical Research Organizations
12.4.5. Forensic Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific dPCR Market Size and Volume Forecast by Type
12.7.1. Consumables
12.7.2. Instruments
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific dPCR Demand Share, 2019-2026
13. Middle East & Africa dPCR Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa dPCR Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa dPCR Market Size and Volume Forecast by Application
13.4.1. Research Laboratories and Academic Institutes
13.4.2. Pharma and Biotech Companies
13.4.3. Hospitals and Diagnostic Centers
13.4.4. Clinical Research Organizations
13.4.5. Forensic Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa dPCR Market Size and Volume Forecast by Type
13.7.1. Consumables
13.7.2. Instruments
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa dPCR Demand Share, 2019-2026
14. Competition Landscape
14.1. Global dPCR Market: Market Share Analysis
14.2. dPCR Distributors and Customers
14.3. dPCR Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bio-Rad Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Fluidigm
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. RainDance Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Becton
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dickinson and Company
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Exiqon
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Formulatrix
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Promega Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sigma-Aldrich
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Stilla Technologies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
